<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Tissue accumulation of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> occurs in classical <z:hpo ids='HP_0002156'>homocystinuria</z:hpo>, a <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disease</z:e> characterized biochemically by <z:chebi fb="0" ids="17755">cystathionine</z:chebi> β-synthase deficiency </plain></SENT>
<SENT sid="1" pm="."><plain>Vascular manifestations such as <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo>, <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo>, and <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> are common in this disease and poorly understood </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we investigated the effect of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> on some parameters of <z:mp ids='MP_0003674'>oxidative stress</z:mp> (<z:chebi fb="0" ids="33202">thiobarbituric acid</z:chebi>-reactive substances, protein <z:chebi fb="1" ids="23019">carbonyl</z:chebi> content, <z:chebi fb="0" ids="51596">2',7'-dichlorofluorescein</z:chebi> fluorescence assay, and total radical-trapping <z:chebi fb="11" ids="22586">antioxidant</z:chebi> potent) and activities of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes (<z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, catalase, and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase) in the rat lung </plain></SENT>
<SENT sid="3" pm="."><plain>Reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> content and <z:chebi fb="105" ids="17234">glucose</z:chebi> 6-phosphate dehydrogenase activity, as well as <z:chebi fb="95" ids="16301">nitrite</z:chebi> levels, were also evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>Wistar rats received daily subcutaneous injections of <z:chebi fb="0" ids="17230">Hcy</z:chebi> (0.3-0.6 μmol/g body weight) from the 6th to the 28th days-of-age and the control group received saline </plain></SENT>
<SENT sid="5" pm="."><plain>One and 12 h after the last injection, rats were killed and the lungs collected </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> increased <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and oxidative damage to protein, and disrupted <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defenses (enzymatic and non-enzymatic) in the lung of rats, characterizing a reliable <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, this amino acid did not alter <z:chebi fb="95" ids="16301">nitrite</z:chebi> levels </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings showed a consistent profile of <z:mp ids='MP_0003674'>oxidative stress</z:mp> in the lung of rats, elicited by <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, which could explain, at least in part, the mechanisms involved in the lung damage that is present in some homocystinuric patients </plain></SENT>
</text></document>